Advertisement
Screener

LISATA THERAPEUTICS, INC. (LSTA) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

2.8 / 5 stars · 68/120 Roast Me

LISATA THERAPEUTICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

LISATA THERAPEUTICS, INC. (LSTA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$2.93 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2026-08-06

  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$2.93M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$4.49M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$2.95M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$4.25M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$16.59M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$19.98M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$20.84M.
  • LISATA THERAPEUTICS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$54.23M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30-$2.93M
10-Q · filed 2026-08-06
-$7.42M
10-Q · filed 2026-08-06
-$10.37M
derived: sum of 3 quarters · filed 2026-08-06
-$14.62M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$4.49M
10-Q · filed 2026-05-11
-$7.44M
derived: sum of 2 quarters · filed 2026-05-11
-$11.69M
derived: sum of 3 quarters · filed 2026-05-11
-$16.35M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$2.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$7.20M
derived: sum of 2 quarters · filed 2026-03-12
-$11.86M
derived: sum of 3 quarters · filed 2026-08-06
-$16.59M
10-K · filed 2026-03-12
2025-09-30-$4.25M
10-Q · filed 2025-11-06
-$8.91M
derived: sum of 2 quarters · filed 2026-08-06
-$13.63M
10-Q · filed 2025-11-06
-$18.24M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$4.66M
10-Q · filed 2026-08-06
-$9.38M
10-Q · filed 2026-08-06
-$13.99M
derived: sum of 3 quarters · filed 2026-08-06
-$18.92M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$4.72M
10-Q · filed 2026-05-11
-$9.33M
derived: sum of 2 quarters · filed 2026-05-11
-$14.26M
derived: sum of 3 quarters · filed 2026-05-11
-$19.31M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31-$4.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$9.54M
derived: sum of 2 quarters · filed 2026-03-12
-$14.58M
derived: sum of 3 quarters · filed 2026-03-12
-$19.98M
10-K · filed 2026-03-12
2024-09-30-$4.93M
10-Q · filed 2025-11-06
-$9.97M
derived: sum of 2 quarters · filed 2025-11-06
-$15.38M
10-Q · filed 2025-11-06
-$20.74M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30-$5.04M
10-Q · filed 2025-08-07
-$10.45M
10-Q · filed 2025-08-07
-$15.81M
derived: sum of 3 quarters · filed 2025-08-07
-$21.07M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31-$5.40M
10-Q · filed 2025-05-08
-$10.77M
derived: sum of 2 quarters · filed 2025-05-08
-$16.03M
derived: sum of 3 quarters · filed 2025-05-08
-$20.05M
derived: sum of 4 quarters · filed 2025-05-08
2023-12-31-$5.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$10.63M
derived: sum of 2 quarters · filed 2025-02-27
-$14.65M
derived: sum of 3 quarters · filed 2025-02-27
-$20.84M
10-K · filed 2025-02-27
2023-09-30-$5.26M
10-Q · filed 2024-11-12
-$9.29M
derived: sum of 2 quarters · filed 2024-11-12
-$15.47M
10-Q · filed 2024-11-12
-$21.46M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$4.03M
10-Q · filed 2024-08-12
-$10.21M
10-Q · filed 2024-08-12
-$16.20M
derived: sum of 3 quarters · filed 2024-08-12
-$53.59M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31-$6.19M
10-Q · filed 2024-05-09
-$12.18M
derived: sum of 2 quarters · filed 2024-05-09
-$49.56M
derived: sum of 3 quarters · filed 2024-05-09
-$56.19M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$43.37M
derived: sum of 2 quarters · filed 2024-02-29
-$50.00M
derived: sum of 3 quarters · filed 2024-02-29
-$54.23M
10-K · filed 2024-02-29
2022-09-30-$37.38M
10-Q · filed 2023-11-02
-$44.01M
derived: sum of 2 quarters · filed 2023-11-02
-$48.23M
10-Q · filed 2023-11-02
-$55.03M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30-$6.63M
10-Q · filed 2023-08-14
-$10.85M
10-Q · filed 2023-08-14
-$17.65M
derived: sum of 3 quarters · filed 2023-08-14
-$24.57M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$4.23M
10-Q · filed 2023-05-09
-$11.02M
derived: sum of 2 quarters · filed 2023-05-09
-$17.95M
derived: sum of 3 quarters · filed 2023-05-09
-$23.63M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$6.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$13.72M
derived: sum of 2 quarters · filed 2023-03-30
-$19.40M
derived: sum of 3 quarters · filed 2023-03-30
-$27.47M
10-K · filed 2023-03-30
2021-09-30-$6.93M
10-Q · filed 2022-11-10
-$12.61M
derived: sum of 2 quarters · filed 2022-11-10
-$20.67M
10-Q · filed 2022-11-10
-$26.10M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$5.68M
10-Q · filed 2022-08-04
-$13.74M
10-Q · filed 2022-08-04
-$19.18M
derived: sum of 3 quarters · filed 2022-08-04
-$24.50M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31-$8.06M
10-Q · filed 2022-05-05
-$13.49M
derived: sum of 2 quarters · filed 2022-05-05
-$18.82M
derived: sum of 3 quarters · filed 2022-05-05
-$12.22M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31-$5.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22
-$10.76M
derived: sum of 2 quarters · filed 2022-03-22
-$4.16M
derived: sum of 3 quarters · filed 2022-03-22
-$8.14M
10-K · filed 2022-03-22
2020-09-30-$5.33M
10-Q · filed 2021-11-04
$1.28M
derived: sum of 2 quarters · filed 2021-11-04
-$2.71M
10-Q · filed 2021-11-04
-$7.66M
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30$6.60M
10-Q · filed 2021-08-05
$2.62M
10-Q · filed 2021-08-05
-$2.34M
derived: sum of 3 quarters · filed 2021-08-05
-$7.23M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31-$3.99M
10-Q · filed 2021-05-06
-$8.94M
derived: sum of 2 quarters · filed 2021-05-06
-$13.84M
derived: sum of 3 quarters · filed 2021-05-06
-$18.97M
derived: sum of 4 quarters · filed 2021-05-06
2019-12-31-$4.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$9.85M
derived: sum of 2 quarters · filed 2021-02-25
-$14.99M
derived: sum of 3 quarters · filed 2021-02-25
-$19.35M
10-K · filed 2021-02-25
2019-09-30-$4.90M
10-Q · filed 2020-11-05
-$10.03M
derived: sum of 2 quarters · filed 2020-11-05
-$14.40M
10-Q · filed 2020-11-05
-$17.96M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$5.14M
10-Q · filed 2020-08-13
-$9.50M
10-Q · filed 2020-08-13
-$13.06M
derived: sum of 3 quarters · filed 2020-08-13
-$16.61M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$4.37M
10-Q · filed 2020-05-07
-$7.92M
derived: sum of 2 quarters · filed 2020-05-07
-$11.47M
derived: sum of 3 quarters · filed 2020-05-07
-$15.55M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31-$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
-$7.11M
derived: sum of 2 quarters · filed 2020-03-05
-$11.18M
derived: sum of 3 quarters · filed 2020-03-05
-$16.17M
10-K · filed 2020-03-05
2018-09-30-$3.55M
10-Q · filed 2019-11-06
-$3.55M
10-Q · filed 2018-11-08
-$7.63M
derived: sum of 2 quarters · filed 2019-11-06
-$12.61M
10-Q · filed 2019-11-06
-$12.61M
10-Q · filed 2018-11-08
-$15.51M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30-$4.08M
10-Q · filed 2019-08-08
-$4.08M
10-Q · filed 2018-08-09
-$9.06M
10-Q · filed 2019-08-08
-$9.06M
10-Q · filed 2018-08-09
-$11.96M
derived: sum of 3 quarters · filed 2019-08-08
-$15.50M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$4.98M
10-Q · filed 2019-05-09
-$4.98M
10-Q · filed 2018-05-10
-$7.88M
derived: sum of 2 quarters · filed 2019-05-09
-$11.43M
derived: sum of 3 quarters · filed 2019-05-09
$27.04M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31-$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
-$6.44M
derived: sum of 2 quarters · filed 2019-03-14
$32.02M
derived: sum of 3 quarters · filed 2019-03-14
$22.23M
10-K · filed 2019-03-14
$22.23M
10-K · filed 2018-03-22
2017-09-30-$3.55M
10-Q · filed 2018-11-08
$34.92M
derived: sum of 2 quarters · filed 2018-11-08
$25.12M
10-Q · filed 2018-11-08
$19.03M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$38.47M
10-Q · filed 2018-08-09
$28.67M
10-Q · filed 2018-08-09
$22.58M
derived: sum of 3 quarters · filed 2018-08-09
$15.29M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$9.79M
10-Q · filed 2018-05-10
-$15.88M
derived: sum of 2 quarters · filed 2018-05-10
-$23.17M
derived: sum of 3 quarters · filed 2018-05-10
-$31.06M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31-$6.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22
-$13.38M
derived: sum of 2 quarters · filed 2018-03-22
-$21.26M
derived: sum of 3 quarters · filed 2018-03-22
-$33.31M
10-K · filed 2018-03-22
2016-09-30-$7.29M
10-Q · filed 2017-11-09
-$15.17M
derived: sum of 2 quarters · filed 2017-11-09
-$27.22M
10-Q · filed 2017-11-09
-$60.45M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30-$7.88M
10-Q · filed 2017-08-10
-$19.93M
10-Q · filed 2017-08-10
-$53.16M
derived: sum of 3 quarters · filed 2017-08-10
-$64.55M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31-$12.05M
10-Q · filed 2017-05-15
-$45.28M
derived: sum of 2 quarters · filed 2017-05-15
-$56.67M
derived: sum of 3 quarters · filed 2017-05-15
-$73.83M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31-$33.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17
-$44.62M
derived: sum of 2 quarters · filed 2017-03-17
-$61.78M
derived: sum of 3 quarters · filed 2017-03-17
-$81.01M
10-K · filed 2017-03-17
2015-09-30-$11.39M
10-Q · filed 2016-11-07
-$28.55M
derived: sum of 2 quarters · filed 2016-11-07
-$47.78M
10-Q · filed 2016-11-07
-$59.47M
derived: sum of 4 quarters · filed 2016-11-07
2015-06-30-$17.16M
10-Q · filed 2016-08-09
-$36.39M
10-Q · filed 2016-08-09
-$48.08M
derived: sum of 3 quarters · filed 2016-08-09
-$65.26M
derived: sum of 4 quarters · filed 2016-08-09
2015-03-31-$19.23M
10-Q · filed 2016-05-05
-$30.92M
derived: sum of 2 quarters · filed 2016-05-05
-$48.10M
derived: sum of 3 quarters · filed 2016-05-05
-$60.87M
derived: sum of 4 quarters · filed 2016-05-05
2014-12-31-$11.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$28.87M
derived: sum of 2 quarters · filed 2016-03-15
-$41.64M
derived: sum of 3 quarters · filed 2016-03-15
-$55.47M
10-K · filed 2016-03-15
2014-09-30-$17.18M
10-Q · filed 2015-11-05
-$29.95M
derived: sum of 2 quarters · filed 2015-11-05
-$43.78M
10-Q · filed 2015-11-05
-$56.49M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30-$12.77M
10-Q · filed 2015-08-06
-$26.60M
10-Q · filed 2015-08-06
-$39.32M
derived: sum of 3 quarters · filed 2016-03-15
-$48.59M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31-$13.83M
10-Q · filed 2015-05-06
-$26.55M
derived: sum of 2 quarters · filed 2016-03-15
-$35.83M
derived: sum of 3 quarters · filed 2016-03-15
-$44.45M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31-$12.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
-$22.00M
derived: sum of 2 quarters · filed 2016-03-15
-$30.62M
derived: sum of 3 quarters · filed 2016-03-15
-$39.49M
10-K · filed 2016-03-15
2013-09-30-$9.28M
10-Q · filed 2014-10-30
-$17.90M
derived: sum of 2 quarters · filed 2014-10-30
-$26.77M
10-Q · filed 2014-10-30
-$42.11M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$8.63M
10-Q · filed 2014-08-07
-$17.49M
10-Q · filed 2014-08-07
-$32.83M
derived: sum of 3 quarters · filed 2015-03-02
-$41.23M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31-$8.86M
10-Q · filed 2014-05-08
-$24.21M
derived: sum of 2 quarters · filed 2015-03-02
-$32.60M
derived: sum of 3 quarters · filed 2015-03-02
-$66.03M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$15.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$23.74M
derived: sum of 2 quarters · filed 2015-03-02
-$57.16M
derived: sum of 3 quarters · filed 2015-03-02
-$66.37M
10-K · filed 2015-03-02
2012-09-30-$8.40M
10-Q · filed 2013-11-07
-$41.82M
derived: sum of 2 quarters · filed 2013-11-07
-$51.03M
10-Q · filed 2013-11-07
-$79.88M
derived: sum of 4 quarters · filed 2013-11-07
2012-06-30-$33.42M
10-Q · filed 2013-08-08
-$42.63M
10-Q · filed 2013-08-08
-$71.48M
derived: sum of 3 quarters · filed 2013-08-08
-$78.81M
derived: sum of 4 quarters · filed 2013-08-08
2012-03-31-$9.21M
10-Q · filed 2013-05-09
-$38.06M
derived: sum of 2 quarters · filed 2013-05-09
-$45.39M
derived: sum of 3 quarters · filed 2013-05-09
-$55.93M
derived: sum of 4 quarters · filed 2013-05-09
2011-12-31-$28.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11
-$36.18M
derived: sum of 2 quarters · filed 2013-03-11
-$46.72M
derived: sum of 3 quarters · filed 2013-03-11
-$56.58M
10-K · filed 2013-03-11
2011-09-30-$7.33M
10-Q · filed 2012-11-13
-$17.87M
derived: sum of 2 quarters · filed 2012-11-13
-$27.73M
10-Q · filed 2012-11-13
-$33.92M
derived: sum of 4 quarters · filed 2012-11-13
2011-06-30-$10.54M
10-Q · filed 2012-08-14
-$20.24M
10-Q · filed 2012-08-14
-$26.59M
derived: sum of 3 quarters · filed 2012-08-15
-$32.59M
derived: sum of 4 quarters · filed 2012-08-15
2011-03-31-$9.70M
10-Q · filed 2012-05-11
-$16.06M
derived: sum of 2 quarters · filed 2012-08-15
-$22.05M
derived: sum of 3 quarters · filed 2012-08-15
-$25.81M
derived: sum of 4 quarters · filed 2012-08-15
2010-12-31-$6.36M
derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15
-$12.35M
derived: sum of 2 quarters · filed 2012-08-15
-$16.11M
derived: sum of 3 quarters · filed 2012-08-15
-$19.40M
8-K · filed 2012-08-15
2010-09-30-$5.99M
10-Q · filed 2011-11-10
-$9.76M
derived: sum of 2 quarters · filed 2011-11-10
-$13.04M
10-Q · filed 2011-11-10
2010-06-30-$3.76M
10-Q · filed 2011-08-12
-$7.05M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
BIOVIE INC. (BIVI)United States$0.012B